Full Press Release Details
Aurora Cannabis to Enter Mexico Market
via Exclusive Supply Arrangement with Farmacias Magistrales
Farmacias is Sole Recipient
of Federal License to Import, Formulate, Store and Sell Medical Cannabis Containing THC
EDMONTON, Dec. 7, 2018 /CNW/ - Aurora
Cannabis Inc. ("Aurora" or the "Company") (TSX: ACB) (NYSE: ACB) (Frankfurt: 21P; WKN: A1C4WM) announced today
that the Company has established an exclusive partnership with Farmacias Magistrales S.A. ("Farmacias"), an established
Mexican pharmaceutical manufacturer and distributer with a broad reach to approximately 80,000 retail points and 500 pharmacies
and hospitals across Mexico. Farmacias recently received the first and only import license granted to date, from the Federal Commission
for Protection Against Health Risks ("COFEPRIS"), the Mexican government body responsible for medical cannabis licensing,
which permits Farmacias to import Aurora medical cannabis products containing THC into Mexico.
Farmacias has also received licenses from COFEPRIS
Importation and storage of raw CBD and THC materials
Manufacture of CDB and THC products
Distribution of CBD and THC products
Farmacias' license to import Aurora's medical
cannabis into Mexico positions Aurora with another first-mover advantage in one of the world's most populous countries, where more
than 130 million people will have federally legal access to a range of Aurora's non-flower medical cannabis products containing
THC and/or CBD. Dried flower containing THC is currently prohibited for domestic cultivation, import or sale in Mexico.
Management Commentary
"This new exclusive partnership further
expands Aurora's early mover advantage in Latin America, allowing us to become a leading player in the development of the medical
cannabis system in Mexico, a legal market of 130 million people," said Terry Booth, CEO of Aurora. "We look forward to
working with Farmacias, and leveraging its strong retail, pharmacy, and hospital networks to provide high-quality, medical grade
cannabis to patients in this new and significant market. We will also offer the Mexican government authorities whatever support
they deem valuable, based on our insights and experience earned from operating in multiple nationally-legal medical cannabis systems
Headquartered in Edmonton, Alberta, Canada
with funded capacity in excess of 500,000 kg per annum and sales and operations in 22 countries across five continents, Aurora
is one of the world's largest and leading cannabis companies. Aurora is vertically integrated and horizontally diversified across
every key segment of the value chain, from facility engineering and design to cannabis breeding and genetics research, cannabis
and hemp production, derivatives, high value-add product development, home cultivation, wholesale and retail distribution.
Highly differentiated from its peers, Aurora
has established a uniquely advanced, consistent and efficient production strategy, based on purpose-built facilities that integrate
leading-edge technologies across all processes, defined by extensive automation and customization, resulting in the massive scale
production of high quality product at low cost. Intended to be replicable and scalable globally, our production facilities are
designed to produce cannabis of significant scale, with high quality, industry-leading yields, and low per gram production costs.
Each of Aurora's facilities is built to meet EU GMP standards, and its first production facility, the recently acquired MedReleaf
Markham facility, and its wholly owned European medical cannabis distributor Aurora Deutschland, have achieved this level of certification.
In addition to the Company's rapid organic
growth and strong execution on strategic M&A, which to date includes 15 wholly owned subsidiary companies - MedReleaf,
CanvasRX, Peloton Pharmaceutical, Aurora Deutschland , H2 Biopharma, Urban Cultivator, BC Northern Lights, Larssen Greenhouses,
CanniMed Therapeutics, Anandia Labs, HotHouse Consulting, MED Colombia, Agropro, Borela, and the pending acquisition of ICC Labs
- Aurora is distinguished by its reputation as a partner and employer of choice in the global cannabis sector, having invested
in and established strategic partnerships with a range of leading innovators, including: Radient Technologies Inc. (TSXV: RTI),
Hempco Food and Fiber Inc. (TSXV: HEMP), Cann Group Ltd. (ASX: CAN), Micron Waste Technologies Inc. (CSE: MWM), Choom Holdings
Inc. (CSE: CHOO), Capcium Inc. (private), Evio Beauty Group (private), Wagner Dimas (private), CTT Pharmaceuticals (OTCC: CTTH),
and Alcanna Inc. (TSX: CLIQ).
Aurora's Common Shares trade on the TSX and
NYSE under the symbol "ACB", and are a constituent of the S&P/TSX Composite Index.
For more information about Aurora, please visit
our investor website, investor.auroramj.com
Aurora Cannabis Inc.
Forward looking statements
This news release includes statements containing
certain "forward-looking information" within the meaning of applicable securities law ("forward-looking statements").
Forward-looking statements are frequently characterized by words such as "plan", "continue", "expect",
"project", "intend", "believe", "anticipate", "estimate", "may", "will",
"potential", "proposed" and other similar words, or statements that certain events or conditions "may"
or "will" occur and include, but are not limited to the variety of cannabis products that Aurora will supply to the adult
use market.. These statements are only predictions. Various assumptions were used in drawing the conclusions or making the projections
contained in the forward-looking statements throughout this news release. Forward-looking statements are based on the opinions
and estimates of management at the date the statements are made, and are subject to a variety of risks and uncertainties and other
factors that could cause actual events or results to differ materially from those projected in the forward-looking statements.
The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking
statements, whether as a result of new information, future events or otherwise, except as expressly required by applicable law.
Neither the TSX, NYSE nor their Regulation
Services Provider (as that term is defined in the policies of the TSX and NYSE) accepts responsibility for the adequacy or accuracy
View original content to download multimedia:http://www.prnewswire.com/news-releases/aurora-cannabis-to-enter-mexico-market-via-exclusive-supply-arrangement-with-farmacias-magistrales-300762006.html
SOURCE Aurora Cannabis Inc.
View original content to download multimedia:
For further information: For Media: Heather MacGregor, +1.416.509.5416,
heather.macgregor@auroramj.com; For Investors: Marc Lakmaaker, +1.647.269.5523, marc.lakmaaker@auroramj.com; Rob Kelly, +1.647.331.7228,
rob.kelly@auroramj.com; U.S. Investors: Phil Carlson / Elizabeth Barker, KCSA Strategic Communications, Phone: (212) 896-1233 /
(212) 896-1203, Email: pcarlson@kcsa.com / ebarker@kcsa.com
CO: Aurora Cannabis Inc.
CNW 13:24e 07-DEC-18